Please assess the completion status of the following clinical trial:

Trial Title: Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Children between 2 to 12 years of age.~2. Children with the diagnosis of asthma having a pram score of more than 4.~3. Children with reactive airways~Exclusion Criteria:~1. Critically ill children who require intubation or mechanical ventilation.~2. Having hypersensitivity or allergy to MgSO4.~3. with history of chronic lung impairment.~4. Whose parents are not giving informed consent for participation in research.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Nebulized Ventolin (Type: ACTIVE_COMPARATOR): Nebulized Ventolin will given to 1st group after every 20 min for 1 hour
- Nebulized Magnesium Sulphate + Ventolin (Type: EXPERIMENTAL): Dose of Nebulized Magnesium sulphate will vary in 3 subgroups.

Based on this trial design, predict the completion outcome and termination type (if applicable).